Topics
April 2013 | Editor's Page: Guest Editorial
What Sequestration Means to Your Practice
Richard Kaiser, MD, and Jonathan L. Prenner, MD
August 12, 2026
NovelMed Advances NM5072 for GA, Complement-Associated Retinal Diseases
August 11, 2026
FDA Accepts Belite Bio’s NDA for Tinlarebant in Stargardt Disease
August 10, 2026
Oculis to Acquire Global Rights to Privosegtor from Accure Therapeutics
August 7, 2026
UK Study Finds Ophthalmic Clinical Letters Increasingly Difficult for Patients to Read
July/August 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
July/August 2026 Supplement
Editorially Independent Content, Supported With Advertising From Astellas
Editorially Independent Content, Supported With Advertising From Astellas and ZEISS
July 2026 Supplement
Free Print Subscription
Email Newsletter
Conference Calendar
_1784132761.jpg?auto=compress,format&w=70)
